A C-degron regulates Chk1 kinase by allowing stability of inactive Chk1 and by making it short- lived upon activation

C-降解子通过维持非活性Chk1的稳定性并使其在激活后迅速消退来调控Chk1激酶。

阅读:1

Abstract

The Arg/N-degron pathway of Saccharomyces cerevisiae is mediated by two interacting E3 ubiquitin ligases, Ubr1 and Ufd4. We show here that the mitotic checkpoint kinase Chk1 bears a C-degron that can be recognized by both Ubr1 and Ufd4. Ubr1 is an E3 that can target both N-degrons and C-degrons. Deleting 4 residues from the C terminus of full-length Chk1(1-527) abrogates the bulk of Ubr1/Ufd4 affinity for the resulting Chk1(1-523), inhibits its polyubiquitylation and degradation, and arrests cell growth. Toxicity of the 4-residue C-terminally (Ct)-deleted Chk1(1-523) was traced to its kinase activity, since the kinase-inactive [Formula: see text] was nontoxic. The L506R mutation is known to activate Chk1 kinase in a way that bypasses other Chk1 activation pathways. Both kinase-active and kinase-inactive Chk1 proteins that contained the L506R mutation ([Formula: see text] and [Formula: see text]) were short-lived in vivo, in contrast to wildtype Chk1(1-527). Furthermore, the catalytic N-terminal (Nt) domain of Chk1 physically interacted with its Ct-domain. These and other results strongly suggested the following mechanism of Chk1 regulation. Ct-residues of Chk1(1-527) are a part of its C-degron, targeted by Ubr1/Ufd4 E3s. But the Ct-domain of Chk1(1-527) (including its C-degron) can also bind to the catalytic Nt-domain. The resulting conformation of Chk1(1-527) is inactive as a kinase and relatively long-lived, since the catalytic Nt-domain sterically sequesters C-degron. An induced (e.g., through a regulatory phosphorylation) dissociation of Ct-domain from Nt-domain activates the catalytic Nt-domain and also exposes the C-degron of Chk1. Thus, activation of Chk1 kinase would make it, simultaneously, a short-lived protein.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。